COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England
- PMID: 35623379
- PMCID: PMC9129256
- DOI: 10.1016/S1473-3099(22)00309-7
COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England
Conflict of interest statement
We declare no competing interests. The UK Health Security Agency has legal permission, provided by Regulation 3 of The Health Service (Control of Patient Information) Regulations 2002, to process patient confidential information for national surveillance of communicable diseases and, as such, individual patient consent is not required to access records.
Figures
References
-
- UK Health Security Agency SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 35. Jan 28, 2022. https://assets.publishing.service.gov.uk/government/uploads/system/uploa...
-
- UK Health Security Agency SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 36. Feb 11, 2022. https://assets.publishing.service.gov.uk/government/uploads/system/uploa...
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical